IGF-1 (growth factor-1) has been widely reported that its expression decreased sharply in patients with chronic liver disease such as steatosis, nonalcoholic steatohepatitis, chronic hepatitis C, cirrhosis, and HCC [23–29]. Here, IGF1 is linked to metabolic dysfunction-associated steatohepatitis.